Drug-Packed Nanoparticles KO Mesothelioma
Targeted method beats traditional chemo
Mesothelioma is a rare and extremely lethal cancer that afflicts about 3,000 people in the United States annually. Those treatments that exist are primitive, painful, and largely unsuccessful. BU researchers are hoping to change that by delivering drugs in polymer-based nanoparticles directly to tumor cells, where they expand and release chemotherapy drugs—like microscopic Trojan horses.
